• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液中的游离κ轻链作为评估多发性硬化症风险转化的生物标志物。

Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis.

作者信息

Menéndez-Valladares P, García-Sánchez M I, Cuadri Benítez P, Lucas M, Adorna Martínez M, Carranco Galán V, García De Veas Silva J L, Bermudo Guitarte C, Izquierdo Ayuso G

机构信息

Unidad de Gestión Clínica Bioquímica Clínica, Hospital Universitario Virgen Macarena, Spain.

Biobanco Hospitalario Virgen Macarena, Biobanco del Sistema Sanitario Público de Andalucía, Spain.

出版信息

Mult Scler J Exp Transl Clin. 2015 Dec 16;1:2055217315620935. doi: 10.1177/2055217315620935. eCollection 2015 Jan-Dec.

DOI:10.1177/2055217315620935
PMID:28607709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5433434/
Abstract

BACKGROUND

Multiple sclerosis (MS) initiates with a first attack or clinically isolated syndrome (CIS). The importance of an early treatment in MS leads to the search, as soon as possible, for novel biomarkers which can predict conversion from CIS to MS.

OBJECTIVE

The purpose of this study was to assess the predictive value of the kappa index ([Formula: see text] index), using kappa free light light chains ([Formula: see text]FLCs) in cerebrospinal fluid (CSF), for the conversion of CIS patients to MS, and compare its accuracy with other parameters used in clinical practice.

METHODS

FLC levels were analysed in CSF from 176 patients: 70 as control group, 77 CIS, and 29 relapsing-remitting MS. FLC levels were quantified by nephelometry.

RESULTS

[Formula: see text] Index sensitivity and specificity (93.1%; 95.7%) was higher than those from the immunoglobulin G (IgG) index (75.9%; 94.3%), and lower than those from oligoclonal IgG bands (OCGBs) (96.5%; 98.6%). The optimal cut-off for [Formula: see text] index was 10.62. Most of the CIS patients with [Formula: see text] index >10.62 presented OCGBs, IgG index >0.56 and fulfilled magnetic resonance imaging (MRI) criteria.

CONCLUSION

CIS patients above [Formula: see text] index cut-off of 10.62 present 7.34-fold risk of conversion to MS than CIS below this value. The [Formula: see text] index correlated with positive OCGBs, IgG index above 0.56 and MRI criteria.

摘要

背景

多发性硬化症(MS)始于首次发作或临床孤立综合征(CIS)。MS早期治疗的重要性促使人们尽快寻找能够预测CIS向MS转化的新型生物标志物。

目的

本研究旨在评估脑脊液(CSF)中κ游离轻链(κFLC)的κ指数([公式:见正文]指数)对CIS患者转化为MS的预测价值,并将其准确性与临床实践中使用的其他参数进行比较。

方法

分析了176例患者脑脊液中的FLC水平:70例作为对照组,77例CIS患者,29例复发缓解型MS患者。通过散射比浊法对FLC水平进行定量。

结果

[公式:见正文]指数的敏感性和特异性(93.1%;95.7%)高于免疫球蛋白G(IgG)指数(75.9%;94.3%),低于寡克隆IgG带(OCGBs)(96.5%;98.6%)。[公式:见正文]指数的最佳截断值为10.62。大多数κ指数>10.62的CIS患者出现OCGBs、IgG指数>0.56并符合磁共振成像(MRI)标准。

结论

κ指数截断值高于10.62的CIS患者转化为MS的风险是该值以下CIS患者的7.34倍。κ指数与阳性OCGBs、IgG指数高于0.56以及MRI标准相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8e/5433434/50edf6a71771/10.1177_2055217315620935-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8e/5433434/b6c01bcddf87/10.1177_2055217315620935-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8e/5433434/403bd346c735/10.1177_2055217315620935-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8e/5433434/50edf6a71771/10.1177_2055217315620935-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8e/5433434/b6c01bcddf87/10.1177_2055217315620935-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8e/5433434/403bd346c735/10.1177_2055217315620935-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8e/5433434/50edf6a71771/10.1177_2055217315620935-fig3.jpg

相似文献

1
Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis.脑脊液中的游离κ轻链作为评估多发性硬化症风险转化的生物标志物。
Mult Scler J Exp Transl Clin. 2015 Dec 16;1:2055217315620935. doi: 10.1177/2055217315620935. eCollection 2015 Jan-Dec.
2
Validation and meta-analysis of kappa index biomarker in multiple sclerosis diagnosis.kappa 指数生物标志物在多发性硬化症诊断中的验证和荟萃分析。
Autoimmun Rev. 2019 Jan;18(1):43-49. doi: 10.1016/j.autrev.2018.07.010. Epub 2018 Nov 5.
3
Prognostic value of free light chains lambda and kappa in early multiple sclerosis.游离轻链 lambda 和 kappa 在多发性硬化症早期的预后价值。
Mult Scler. 2017 Oct;23(11):1496-1505. doi: 10.1177/1352458516681503. Epub 2016 Nov 29.
4
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.游离免疫球蛋白轻链脑脊液浓度在临床孤立综合征转化为多发性硬化症中的诊断和预后价值
PLoS One. 2015 Nov 25;10(11):e0143375. doi: 10.1371/journal.pone.0143375. eCollection 2015.
5
The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.寡克隆带在卡帕无轻链时代诊断多发性硬化症中的持续意义。
Int J Mol Sci. 2018 Nov 29;19(12):3796. doi: 10.3390/ijms19123796.
6
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.脑脊液κ 游离轻链在多发性硬化症诊断中的应用:系统评价和荟萃分析。
Mult Scler. 2023 Feb;29(2):169-181. doi: 10.1177/13524585221134213. Epub 2022 Dec 1.
7
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.脑脊液游离轻链与寡克隆带在多发性硬化症中的生物标志物比较。
J Neuroimmunol. 2020 Feb 15;339:577108. doi: 10.1016/j.jneuroim.2019.577108. Epub 2019 Nov 7.
8
Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.脑脊液游离轻链。不同方法检测鞘内合成的比较。
Clin Chem Lab Med. 2019 Sep 25;57(10):1574-1586. doi: 10.1515/cclm-2018-1300.
9
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.游离κ轻链作为多发性硬化症和临床孤立综合征诊断生物标志物的验证:一项多中心研究。
Mult Scler. 2016 Apr;22(4):502-10. doi: 10.1177/1352458515594044. Epub 2015 Jul 21.
10
Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.脑脊液游离轻链κ和κ指数在多发性硬化症的诊断中与寡克隆带的表现相当。
Clin Chem Lab Med. 2018 Dec 19;57(2):210-220. doi: 10.1515/cclm-2018-0400.

引用本文的文献

1
Multiple Sclerosis: From the Application of Oligoclonal Bands to Novel Potential Biomarkers.多发性硬化症:从寡克隆带的应用到新的潜在生物标志物。
Int J Mol Sci. 2024 May 15;25(10):5412. doi: 10.3390/ijms25105412.
2
Concordance rate between oligoclonal bands and the Kappa index in patients with suspected multiple sclerosis (MS).寡克隆带与可疑多发性硬化症(MS)患者的 Kappa 指数的符合率。
Arq Neuropsiquiatr. 2024 Mar;82(3):1-5. doi: 10.1055/s-0044-1779690. Epub 2024 Mar 14.
3
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.

本文引用的文献

1
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.多发性硬化症患者脑脊液中的分子生物标志物。
Autoimmun Rev. 2015 Oct;14(10):903-13. doi: 10.1016/j.autrev.2015.06.001. Epub 2015 Jun 10.
2
Long-term epidemiology of multiple sclerosis in the Northern Seville District.塞维利亚北部地区多发性硬化症的长期流行病学研究。
Acta Neurol Scand. 2015 Aug;132(2):111-7. doi: 10.1111/ane.12363. Epub 2015 Feb 4.
3
High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
确定κ 游离轻链指数和寡克隆带的最佳组合,以准确诊断多发性硬化症。
Front Immunol. 2023 Oct 25;14:1288169. doi: 10.3389/fimmu.2023.1288169. eCollection 2023.
4
Kappa free light chains index in multiple sclerosis very long-term prognosis.多发性硬化症的卡帕无轻链指数与极长期预后。
Front Immunol. 2023 Oct 11;14:1223514. doi: 10.3389/fimmu.2023.1223514. eCollection 2023.
5
Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis.鞘内κ 游离轻链合成与复发缓解型多发性硬化的预后不良相关。
J Neurol. 2023 Oct;270(10):4800-4811. doi: 10.1007/s00415-023-11817-9. Epub 2023 Jun 14.
6
Free Light Chains and as New Biomarkers of Selected Diseases.游离轻链及其作为某些疾病新型生物标志物的应用。
Int J Mol Sci. 2023 May 31;24(11):9531. doi: 10.3390/ijms24119531.
7
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.脑脊液游离轻链 κ 对多发性硬化症的诊断价值:共识声明。
Mult Scler. 2023 Feb;29(2):182-195. doi: 10.1177/13524585221134217. Epub 2022 Dec 17.
8
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.脑脊液κ 游离轻链在多发性硬化症诊断中的应用:系统评价和荟萃分析。
Mult Scler. 2023 Feb;29(2):169-181. doi: 10.1177/13524585221134213. Epub 2022 Dec 1.
9
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.卡帕游离轻链生物标志物对多发性硬化症的诊断具有较高的效能:一项大型多中心队列研究。
Neurol Neuroimmunol Neuroinflamm. 2022 Nov 14;10(1). doi: 10.1212/NXI.0000000000200049. Print 2023 Jan.
10
Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.用于优化多发性硬化症患者生物学研究的鞘内B细胞相关标志物。
Sci Rep. 2022 Sep 30;12(1):16425. doi: 10.1038/s41598-022-19811-3.
疑似多发性硬化症患者脑脊液κ游离轻链升高具有高敏感性和特异性。
J Neuroimmunol. 2014 Nov 15;276(1-2):175-9. doi: 10.1016/j.jneuroim.2014.08.003. Epub 2014 Aug 8.
4
Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.脑脊液免疫球蛋白 κ 轻链在临床孤立综合征和多发性硬化中的变化。
PLoS One. 2014 Apr 2;9(4):e88680. doi: 10.1371/journal.pone.0088680. eCollection 2014.
5
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.游离κ轻链:在多发性硬化症和临床孤立综合征中的诊断及预后相关性
PLoS One. 2014 Feb 25;9(2):e89945. doi: 10.1371/journal.pone.0089945. eCollection 2014.
6
Revised diagnostic criteria of multiple sclerosis.多发性硬化症的修订诊断标准。
Autoimmun Rev. 2014 Apr-May;13(4-5):518-24. doi: 10.1016/j.autrev.2014.01.012. Epub 2014 Jan 12.
7
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.脑脊液中κFLC 和 κ 指数的测定:评估鞘内免疫球蛋白合成的有效替代方法。
J Neuroimmunol. 2013 Oct 15;263(1-2):116-20. doi: 10.1016/j.jneuroim.2013.07.006. Epub 2013 Aug 1.
8
Multiple sclerosis: Oligoclonal bands--a useful tool to avoid MS misdiagnosis.多发性硬化症:寡克隆带——避免多发性硬化症误诊的有用工具。
Nat Rev Neurol. 2013 Jun;9(6):303-4. doi: 10.1038/nrneurol.2013.74. Epub 2013 Apr 16.
9
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.脑脊液分析在多发性硬化症患者中的应用。
Nat Rev Neurol. 2013 May;9(5):267-76. doi: 10.1038/nrneurol.2013.41. Epub 2013 Mar 26.
10
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.多发性硬化症中的脑脊液和尿液生物标志物
Acta Neurol Scand. 2013 Nov;128(5):321-7. doi: 10.1111/ane.12119. Epub 2013 Mar 7.